Organogenesis Holdings Inc.
ORGO
$2.62
$0.041.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 225.07M | 150.49M | 100.78M | 86.69M | 126.66M |
| Total Other Revenue | 536.00K | 377.00K | 226.00K | -- | -- |
| Total Revenue | 225.61M | 150.86M | 101.01M | 86.69M | 126.66M |
| Cost of Revenue | 49.92M | 36.25M | 27.63M | 23.72M | 31.05M |
| Gross Profit | 175.69M | 114.61M | 73.38M | 62.97M | 95.61M |
| SG&A Expenses | 100.17M | 79.23M | 73.81M | 72.51M | 73.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.38M | 128.70M | 111.84M | 106.87M | 116.44M |
| Operating Income | 65.23M | 22.17M | -10.83M | -20.18M | 10.22M |
| Income Before Tax | 63.43M | 21.16M | -11.83M | -25.78M | 10.25M |
| Income Tax Expenses | 19.73M | -407.00K | -2.44M | -6.94M | 2.58M |
| Earnings from Continuing Operations | 43.70M | 21.57M | -9.39M | -18.84M | 7.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.70M | 21.57M | -9.39M | -18.84M | 7.67M |
| EBIT | 65.23M | 22.17M | -10.83M | -20.18M | 10.22M |
| EBITDA | 70.09M | 27.04M | -6.26M | -15.89M | 14.67M |
| EPS Basic | 0.28 | 0.11 | -0.06 | -0.17 | 0.05 |
| Normalized Basic EPS | 0.32 | 0.11 | -0.05 | -0.10 | 0.05 |
| EPS Diluted | 0.25 | 0.11 | -0.06 | -0.17 | 0.04 |
| Normalized Diluted EPS | 0.29 | 0.11 | -0.05 | -0.10 | 0.05 |
| Average Basic Shares Outstanding | 126.92M | 126.88M | 126.86M | 126.30M | 129.68M |
| Average Diluted Shares Outstanding | 140.96M | 130.85M | 126.86M | 126.30M | 132.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |